199 related articles for article (PubMed ID: 31807518)
1. Incidence and survival outcomes of early male breast cancer: a population-based comparison with early female breast cancer.
Wang Y; Chen K; Yang Y; Tan L; Chen L; Zhu L; Su F; Liu X; Li S
Ann Transl Med; 2019 Oct; 7(20):536. PubMed ID: 31807518
[TBL] [Abstract][Full Text] [Related]
2. Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
Wang B; Wang H; Zhao A; Zhang M; Yang J
BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
[TBL] [Abstract][Full Text] [Related]
3. Survival Comparisons Between Early Male and Female Breast Cancer Patients.
Wang K; Wang QJ; Xiong YF; Shi Y; Yang WJ; Zhang X; Li HY
Sci Rep; 2018 Jun; 8(1):8900. PubMed ID: 29891971
[TBL] [Abstract][Full Text] [Related]
4. Male breast cancer in the veterans affairs population: a comparative analysis.
Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
[TBL] [Abstract][Full Text] [Related]
5. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
Li X; Yang J; Krishnamurti U; Huo L; Ward KC; O'Regan R; Peng L
Clin Breast Cancer; 2017 Aug; 17(5):356-366. PubMed ID: 28576631
[TBL] [Abstract][Full Text] [Related]
6. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).
Yu XF; Yang HJ; Yu Y; Zou DH; Miao LL
PLoS One; 2015; 10(8):e0136670. PubMed ID: 26313461
[TBL] [Abstract][Full Text] [Related]
7. Hormone receptor-positive breast cancer and black race: does sex matter?
Eskander MF; Li Y; Bhattacharyya O; Tsung A; Oppong BA; Hamad A; Gatti-Mays M; Obeng-Gyasi S
Breast Cancer Res Treat; 2021 Nov; 190(1):111-119. PubMed ID: 34383180
[TBL] [Abstract][Full Text] [Related]
8. Men and women show similar survival outcome in stage IV breast cancer.
Wu SG; Zhang WW; Liao XL; Sun JY; Li FY; Su JJ; He ZY
Breast; 2017 Aug; 34():115-121. PubMed ID: 28577471
[TBL] [Abstract][Full Text] [Related]
9. Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis.
Yu E; Stitt L; Vujovic O; Joseph K; Assouline A; Younus J; Perera F; Tai P
Cureus; 2015 Oct; 7(10):e355. PubMed ID: 26623210
[TBL] [Abstract][Full Text] [Related]
10. Presentation and survival by hormonal receptor status in metaplastic breast cancer: A propensity score-matched analysis.
Wang S; Hu J; Zhang Y; Shen J; Dong F; Zhang X; Lu C; Shang D
Breast; 2021 Dec; 60():168-176. PubMed ID: 34653726
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Analysis of Primary Breast Signet Ring Cell Carcinoma and Mucinous Breast Adenocarcinoma: A SEER Population-Based Study.
Wang S; Zhang Y; Yin F; Zhang X; Yang Z; Wang X
Front Oncol; 2021; 11():783631. PubMed ID: 34956901
[TBL] [Abstract][Full Text] [Related]
12. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the distinct features of metastasis male breast cancer and its effect on overall survival based on the SEER database compared with female breast cancer.
Li H; Zhang Y; Teh MS; Limaye S; Cavalcante FP; Shen JB
Transl Cancer Res; 2023 Sep; 12(9):2371-2378. PubMed ID: 37859736
[TBL] [Abstract][Full Text] [Related]
14. A Novel Nomogram for Predicting Breast Cancer-specific Survival in Male Patients.
Zhou Q; Zhang Q; Zhao S; Zhang Y; Wang Q; Li J
Am J Clin Oncol; 2022 Oct; 45(10):427-437. PubMed ID: 36106711
[TBL] [Abstract][Full Text] [Related]
15. Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer.
Eggemann H; Altmann U; Costa SD; Ignatov A
J Cancer Res Clin Oncol; 2018 Feb; 144(2):337-341. PubMed ID: 29098396
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic characteristics and prognosis for male breast cancer compared to female breast cancer.
Yao N; Shi W; Liu T; Siyin ST; Wang W; Duan N; Xu G; Qu J
Sci Rep; 2022 Jan; 12(1):220. PubMed ID: 34997151
[TBL] [Abstract][Full Text] [Related]
17. Male breast cancer differs from female breast cancer in molecular features that affect prognoses and drug responses.
Li Y; Guo Y; Chen F; Cui Y; Chen X; Shi G
Transl Oncol; 2024 Jul; 45():101980. PubMed ID: 38701649
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database: Matched-Pair Analysis of Patients With Female Breast Cancer.
Choi MY; Lee SK; Lee JE; Park HS; Lim ST; Jung Y; Ko BK; Nam SJ;
Medicine (Baltimore); 2016 Apr; 95(16):e3299. PubMed ID: 27100414
[TBL] [Abstract][Full Text] [Related]
19. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.
Wang XX; Jiang YZ; Liu XY; Li JJ; Song CG; Shao ZM
Oncotarget; 2016 Apr; 7(16):22665-73. PubMed ID: 27009810
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Post-Mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: A Propensity Score-Matched Analysis of the SEER Database.
Hu J; Tan J; Dong F; Zhang X; Ming J; Huang T
Front Oncol; 2021; 11():593121. PubMed ID: 35096554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
